A Multinational European Study of Patient Preferences for Novel Diagnostics to Manage Antimicrobial Resistance.
David John MottGrace HampsonMartin J LlewelynJorge Mestre-FerrandizMichael M HopkinsPublished in: Applied health economics and health policy (2020)
Patients in different European countries do not have the same preferences for the attributes of diagnostic tests to manage AMR in primary care. Failure to account for such differences during test development could reduce test uptake, result in continued overuse of antibiotics, and hamper marketisation.